APC and colorectal carcinoma: Wnt/β-catenin is activated in CRC as a direct consequence of APC mutations and in kidney cells in DKD [79], protecting glomerular mesangial cells from high-glucose-mediated cell apoptosis [80] but causing podocyte dysfunction and proteinuria [79].